Related Experiment Videos
[Smith-Lemli-Opitz syndrome. Cardiologic considerations (author's transl)]
Anales Espanoles De Pediatria
|November 1, 1975
Summary
A new Smith-Lemli-Opitz Syndrome case reveals an un previously documented congenital heart defect. This finding expands understanding of the syndrome
Area of Science:
- Genetics
- Developmental Biology
- Cardiology
Background:
- Smith-Lemli-Opitz Syndrome (SLOS) is an autosomal recessive disorder caused by mutations in the DHCR7 gene, leading to cholesterol biosynthesis defects.
- SLOS is associated with a spectrum of congenital anomalies, including developmental delay, dysmorphic features, and various organ malformations.
- Congenital heart defects (CHDs) are recognized complications of SLOS, but specific types and their prevalence require further elucidation.
Observation:
- This report details a novel case of Smith-Lemli-Opitz Syndrome in a patient presenting with a unique form of congenital cardiopathy.
- The observed cardiac anomaly has not been previously associated with or described in the context of SLOS.
Findings:
- The case highlights a previously unrecognized association between Smith-Lemli-Opitz Syndrome and a specific type of congenital heart defect.
- Detailed clinical and genetic analysis confirmed the diagnosis of SLOS and characterized the novel cardiac presentation.
Implications:
- This finding expands the known spectrum of clinical manifestations in Smith-Lemli-Opitz Syndrome.
- It underscores the importance of comprehensive cardiac evaluation in patients diagnosed with SLOS.
- Further research is warranted to investigate the underlying mechanisms linking DHCR7 mutations to this specific congenital cardiopathy and its potential impact on SLOS prognosis.